Related Experiment Video
Updated: Jun 5, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline
Chetan D Patel1, Vijay Babu Balakrishnan, Lalit Kumar
1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi-110029, India. chetantruptipatel@hotmail.com
Anthracycline chemotherapy can cause cardiotoxicity. This study found that left ventricular diastolic function (LVDF) declines before left ventricular systolic function (LVSF) in patients undergoing this treatment.
Area of Science:
- Cardiology
- Oncology
- Pharmacology
Background:
- Cardiotoxicity is a significant complication of anthracycline chemotherapy.
- Early detection of cardiac dysfunction is crucial for patient management.
Purpose of the Study:
- To investigate whether left ventricular diastolic function (LVDF) deteriorates earlier than left ventricular systolic function (LVSF) in patients receiving anthracyclines.
- To assess changes in cardiac function during anthracycline treatment.
Main Methods:
- Prospective study of 58 patients undergoing anthracycline chemotherapy.
- Evaluation of left ventricular systolic function (LVSF) using left ventricular ejection fraction (LVEF) and peak ejection rate (PER) via equilibrium radionuclide angiography (ERNA).
- Assessment of left ventricular diastolic function (LVDF) using peak filling rate (PFR) and other diastolic parameters from ERNA.
Main Results:
- A significant decrease in LVEF and PER was observed between cumulative doses of 139 mg/m² (S1) and 308 mg/m² (S2).
- A significant decrease in PFR was noted between baseline (S0) and 139 mg/m² (S1).
- These findings indicate an earlier decline in diastolic function compared to systolic function.
Conclusions:
- Left ventricular diastolic function (LVDF) deteriorates earlier than left ventricular systolic function (LVSF) in patients treated with anthracyclines.
- Monitoring LVDF may allow for earlier detection of cardiotoxicity during anthracycline chemotherapy.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Mitral Regurgitation I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

